Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [31] The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study
    Zhou, Lijuan
    Sun, Hui
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [32] Symptomatic remission in previously untreated patients with schizophrenia:: 2-year results from the SOHO study
    Novick, Diego
    Haro, Josep Maria
    Suarez, David
    Lambert, Martin
    Lepine, Jean-Pierre
    Naber, Dieter
    PSYCHOPHARMACOLOGY, 2007, 191 (04) : 1015 - 1022
  • [33] Outcome of suicidal patients with schizophrenia: results from a naturalistic study
    Schennach-Wolff, R.
    Jaeger, M.
    Seemueller, F.
    Obermeier, M.
    Schmauss, M.
    Laux, G.
    Pfeiffer, H.
    Naber, D.
    Schmidt, L. G.
    Gaebel, W.
    Klosterkoetter, J.
    Heuser, I.
    Maier, W.
    Lemke, M. R.
    Ruether, E.
    Klingberg, S.
    Gastpar, M.
    Moeller, H.-J.
    Riedel, M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2010, 121 (05) : 359 - 370
  • [34] Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia Thirty-Six-Month Results From the European Schizophrenia Outpatient Health Outcomes Study
    Novick, Diego
    Haro, Josep Maria
    Bertsch, Jordan
    Haddad, Peter M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) : 531 - 540
  • [35] Hostility and depressive mood: results from the Whitehall II prospective cohort study
    Nabi, H.
    Singh-Manoux, A.
    Ferrie, J. E.
    Marmot, M. G.
    Melchior, M.
    Kivimaeki, M.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (03) : 405 - 413
  • [36] Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
    Roberto Brugnoli
    Diego Novick
    Josep Maria Haro
    Andrea Rossi
    Marco Bortolomasi
    Sonia Frediani
    Giuseppe Borgherini
    BMC Psychiatry, 12
  • [37] Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
    Brugnoli, Roberto
    Novick, Diego
    Maria Haro, Josep
    Rossi, Andrea
    Bortolomasi, Marco
    Frediani, Sonia
    Borgherini, Giuseppe
    BMC PSYCHIATRY, 2012, 12
  • [38] Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
    Kautzky, A.
    Dold, M.
    Bartova, L.
    Spies, M.
    Kranz, G. S.
    Souery, D.
    Montgomery, S.
    Mendlewicz, J.
    Zohar, J.
    Fabbri, C.
    Serretti, A.
    Lanzenberger, R.
    Dikeos, D.
    Rujescu, D.
    Kasper, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (01) : 78 - 88
  • [39] The Schizophrenia Outpatient Health Outcomes (SOHO) study:: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
    Ciudad, Antonio
    Haro, Josep Maria
    Alonso, Jordi
    Bousono, Manuel
    Suarez, David
    Novick, Diego
    Gilaberte, Inmaculada
    EUROPEAN PSYCHIATRY, 2008, 23 (01) : 1 - 7
  • [40] Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study
    Brnabic, A. J. M.
    Kelin, K.
    Ascher-Svanum, H.
    Montgomery, W.
    Kadziola, Z.
    Karagianis, J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 945 - 953